Solid Biosciences (SLDB)
US Market

Solid Biosciences (SLDB) Financial Statements


Solid Biosciences Financial Overview

Solid Biosciences's market cap is currently ―. The company's EPS TTM is $-4.832; its P/E ratio is -2.95; Solid Biosciences is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.66. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue--$ 517.00K-$ 0.00
Gross Profit--$ 517.00K--
EBIT$ -20.98M$ -24.63M$ -31.75M$ -34.95M$ -21.13M
EBITDA$ -21.38M$ -23.98M$ -30.89M$ -34.68M$ -20.69M
Net Income Common Stockholders$ -20.98M$ -24.63M$ -30.07M$ -15.15M$ -20.41M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 142.88M$ 160.19M$ 185.51M$ 213.72M$ 142.16M
Total Assets$ 184.73M$ 205.14M$ 229.59M$ 260.25M$ 184.47M
Total Debt$ 25.04M$ 25.50M$ 25.77M$ 26.18M$ 25.69M
Net Debt$ -117.85M$ -134.69M$ -159.73M$ -187.55M$ -116.47M
Total Liabilities$ 40.37M$ 40.57M$ 45.80M$ 48.59M$ 41.20M
Stockholders Equity$ 144.36M$ 163.73M$ 183.79M$ 211.67M$ 143.28M
Cash Flow-
Free Cash Flow$ -18.28M$ -28.00M$ -28.50M$ -35.34M$ -21.27M
Operating Cash Flow$ -17.90M$ -27.46M$ -28.00M$ -34.48M$ -20.43M
Investing Cash Flow$ -24.64M$ -48.23M$ 37.26M$ 66.10M$ 14.91M
Financing Cash Flow-$ 2.62M-$ 74.74M$ -1.00K
Currency in USD

Solid Biosciences Earnings and Revenue History

Solid Biosciences Debt to Assets

Solid Biosciences Cash Flow

Solid Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis